Zusammenfassung
Am Beispiel von Resorcinol, einem weitverbreiteten Haarfarbstoff, stellt dieser Übersichtbeitrag dar, wie die Daten zur Hautsensibilisierung und Hautexposition aus der SCCS (Scientific Committee on Consumer Safety) opinion (Wissenschaftliches Berater-Gremium bei der Europäischen Union [EU]) und aus anderen Quellen verwendet werden, um eine quantitative Risikobewertung (QRA) durchzuführen. Hierbei wird bewertet, welche Konzentration in Haarfarbprodukten maximal eingesetzt werden kann, ohne dass die Neuentstehung einer Hautsensibilisierung zu erwarten ist. Hierbei liegt der Fokus darauf, die Entstehung (Induktion) einer Kontaktallergie zu vermeiden. Epidemiologische Daten zur Kontaktallergie gegen Resorcinol – wie sie z. B. in Deutschland vom IVDK (Informationsverbund Dermatologischer Kliniken) erarbeitet werden, sind dabei eine wichtige Informationsquelle, die hilft, die Qualität und Effektivität des QRA zu beurteilen.
Abstract
Resorcinol is a frequently used hair dye, whose quantitative risk assessment (QRA) for hair color products is presented in this review as an example to assess its skin sensitization risk after topical application. Its purpose is to determine the maximum concentration that can be used without expecting skin sensitization to occur. The focus is to prevent the de novo development of a contact allergy. Epidemiological data which are provided via dermatological surveillance, e.g., by the IVDK (Information Network of Departments of Dermatology) in Germany, are an important source of information that help to assess the quality and the effectivity of the QRA.
Literatur
Aeby P, Sieber T, Beck H, Gerberick GF, Goebel C (2009) Skin sensitization to p‑phenylenediamine: the diverging roles of oxidation and N‑acetylation for dendritic cell activation and the immune response. J Invest Dermatol 129(1):99–109
Barbaud A, Reichert-Penetrat S, Trechot P, Granel F, Schmutz JL (2001) Sensitization to resorcinol in a prescription verrucide preparation: unusual systemic clinical features and prevalence. Ann Dermatol Venereol 128(5):615–618
Basketter DA, Sanders D, Jowsey IR (2007) The skin sensitization potential of resorcinol: experience with the local lymph node assay. Contact Dermatitis 56(4):196–200
ECETOC (2009) Potency values from the local lymph node assay: application to classification, labelling and risk assessment ECETOC Dokument no. 46. Ecetoc, Brussels
Eskes C, Hennen J, Schellenberger MT, Hoffmann S, Frey S, Goldinger-Oggier D, Peter N, Van Vliet E, Blömeke B (2019) The HaCaT/THP‑1 Cocultured Activation Test (COCAT) for skin sensitization: a study of intra-lab reproducibility and predictivity. ALTEX. https://doi.org/10.14573/altex.1905031
Ezendam J, Braakhuis HM, Vandebriel RJ (2016) State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies. Arch Toxicol 90(12):2861–2883
Genies C, Jamin EL, Debrauwer L, Zalko D, Person EN, Eilstein J, Gregoire S, Schepky A, Lange D, Ellison C, Roe A, Salhi S, Cubberley R, Hewitt NJ, Rothe H, Klaric M, Duplan H, Jacques-Jamin C (2019) Comparison of the metabolism of 10 chemicals in human and pig skin explants. J Appl Toxicol 39(2):385–397
Goebel C, Kosemund-Meyen K, Gargano EM, Politano V, von Bölcshazy G, Zupko K, Jaiswal N, Zhang J, Martin S, Neumann D, Rothe H (2017) Non-animal skin sensitization safety assessments for cosmetic ingredients—What is possible today? Curr Opin Toxicol 5:46–54
Goebel C, Diepgen TL, Blomeke B, Gaspari AA, Schnuch A, Fuchs A, Schlotmann K, Krasteva M, Kimber I (2018) Skin sensitization quantitative risk assessment for occupational exposure of hairdressers to hair dye ingredients. Regul Toxicol Pharmacol 95:124–132
Goebel C, Diepgen TL, Krasteva M, Schlatter H, Nicolas JF, Blomeke B, Coenraads PJ, Schnuch A, Taylor JS, Pungier J, Fautz R, Fuchs A, Schuh W, Gerberick GF, Kimber I (2012) Quantitative risk assessment for skin sensitisation: consideration of a simplified approach for hair dye ingredients. Regul Toxicol Pharmacol 64(3):459–465
Huth L, Moss E, Huth S, Skazik C, Karlberg A, Lepoittevin JP, Baron JM, Merk HF (2017) 429 prohapten-activation by human cutaneous cytochrome P450 isoenzymes—identified with a modified KeratinoSens assay. J Investig Dermatol 137(10):265
Kimber I, Gerberick GF, Basketter DA (2017) Quantitative risk assessment for skin sensitization: success or failure? Regul Toxicol Pharmacol 83:104–108
Kolle SN, Natsch A, Gerberick GF, Landsiedel R (2019) A review of substances found positive in 1 of 3 in vitro tests for skin sensitization. Regul Toxicol Pharmacol 106:352–368
Natsch A, Haupt T (2013) Utility of rat liver S9 fractions to study skin-sensitizing prohaptens in a modified KeratinoSens assay. Toxicol Sci 135(2):356–368
Nukada Y, Ashikaga T, Sakaguchi H, Sono S, Mugita N, Hirota M, Miyazawa M, Ito Y, Sasa H, Nishiyama N (2011) Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT). Contact Dermatitis 65(6):343–353
SCCP (2005) Memorandum classification and categorization of skin sensitisers and grading of test reactions. 20 September 2005. SCCP/0919/05
SCCS (2010) Opinion on resorcinol (23 March 2010)
SCCS (2018) SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation 10th revision, 24–25 October 2018, SCCS/1602/18
Sosted H, Rustemeyer T, Goncalo M, Bruze M, Goossens A, Gimenez-Arnau AM, Le Coz CJ, White IR, Diepgen TL, Andersen KE, Agner T, Maibach H, Menne T, Johansen JD (2013) Contact allergy to common ingredients in hair dyes. Contact Dermatitis 69(1):32–39
Uter W, Aalto-Korte K, Agner T, Andersen KE, Bircher AJ, Brans R, Bruze M, Diepgen TL, Foti C, Gimenez Arnau A, Goncalo M, Goossens A, McFadden J, Paulsen E, Svedman C, Rustemeyer T, White IR, Wilkinson M, Johansen JD (2019) The epidemic of methylisothiazolinone contact allergy in Europe: follow-up on changing exposures. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.15875
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Goebel und M. Kock sind Mitarbeiter von COTY Wella Toxicology. H.F. Merk gibt an, Honorare für Beratungsleistungen von Johnson& Johnson, Grünenthal, COTY Wella und Meda erhalten zu haben.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Goebel, C., Kock, M. & Merk, H. Toxikologische Risikobewertung am Beispiel einer möglichen Kontaktsensibilisierung auf Resorcinol. Hautarzt 70, 948–952 (2019). https://doi.org/10.1007/s00105-019-04510-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-019-04510-4